Articles related to PARKINSON'S DISEASE (PD)

Identifying early symptoms like loss of smell and constipation can lead to a timely diagnosis of Parkinson’s disease, facilitating earlier intervention and potentially slowing disease progression.

An innovative blood test using artificial intelligence has shown the potential to detect Parkinson’s disease up to seven years before symptoms appear, offering new possibilities for early intervention and treatment.

Non-invasive digital health tools, including wearable sensors and tremor-suppressing devices, are emerging as valuable adjuncts to traditional treatments for tremor management, significantly enhancing patient autonomy and quality of life.

Understanding the link between certain medications and the onset of tremors is crucial for effective patient management, especially as these symptoms can often be mitigated by adjusting medication doses.

Manifest Technologies is spearheading the use of AI in developing targeted treatments for CNS disorders, aiming to refine patient selection in clinical trials and enhance therapeutic outcomes.

This study sheds light on lixisenatide’s potential in Parkinson’s disease, showing a notable slowing of motor disability progression, although accompanied by gastrointestinal side effects, underlining the importance of further research to validate these findings.